• vaccine2.jpg

    Coronavirus vaccine tracker: how close are we to a vaccine?

    30 Jul, 2020
    More than 140 teams of researchers are racing to develop a safe and effective coronavirus vaccine.

    Researchers around the world are racing to develop a vaccine against Covid-19, with more than 140 candidate vaccines now tracked by the World Health Organization (WHO).

    Vaccines normally require years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine within 12 to 18 months.

    Vaccines mimic the...
  • vacuna-covid19.jpg

    Coronavirus: Protein treatment trial 'a breakthrough'

    28 Jul, 2020

    The preliminary results of a clinical trial suggest a new treatment for Covid-19 reduces the number of patients needing intensive care, according to the UK company that developed it.

    The treatment from Southampton-based biotech Synairgen uses a protein called interferon beta which the body produces when it gets a viral infection.

    The protein is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, in the hope that it will stimulate an immune respon...
  • good_news.png

    Dexamethasone in Hospitalized Patients with Covid-19 | NEJM

    19 Jul, 2020


    An study of the RECOVERY Group bring good news about the use of Dexamethasone in COVID-19 patients. 

    Background

    Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death.

    Methods

    In this controlled, open-label trial comparing a range of possible treatments in patients who were hospitalized with Covid-19, we ra...
  • vaccine4.jpg

    $2bn global coronavirus vaccine fund announced at Gavi summit

    5 Jun, 2020

    A $2bn procurement fund aimed at ensuring that poorer countries can access doses of a potential coronavirus vaccine has been announced at a virtual summit hosted by the UK.



    The announcement was made at the third Gavi vaccine alliance replenishment summit, a virtual pledging event that separately raised $8.8bn, above the target of $7.4bn, for the private-public alliance’s general work on immunising millions of people worldwide from longstanding diseases such as measles.
    <...
  • vaxin.jpg

    Fauci says he's optimistic about coronavirus vaccine protection, but concerned about how long that protection will last

    4 Jun, 2020

    The USA's leading infectious disease expert Dr. Anthony Fauci said he’s “cautiously optimistic” a coronavirus vaccine will provide some protection against SARS-CoV-2 and COVID-19, the illness it causes, but is concerned about how long that protection could last.

    In an interview with JAMA editor-in-chief Howard Bauchner Tuesday, the director of the National Institute of Allergy and Infectious Diseases questioned the "durability" of candidate vaccines.

    Click here for refe...
  • vaccine3.jpg

    In-home antibody test shows promise; recovering surgery patients at risk from coronavirus

    2 Jun, 2020
    The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

    In-home COVID-19 antibody test shows high accuracy

    Recovering surgery patients at risk from coronavirus

    Immune system overreaction may not be cause of bad outcomes

    COVID-19 survivors will need rehab therapy, experts say


    Click here for reference



  • trace.jpg

    Effective test, track and tracing 'can reduce lost working hours by 50%'

    29 May, 2020

    An effective track-and-trace system to prevent a second coronavirus peak will not only save lives, it could reduce the number of working hours lost to illness by as much as 50%, according to a major global study.

    The International Labour Organisation said the effective testing and tracing of infections was essential if employers wanted staff to return to work and for them to stay healthy.


    Click here for reference







  • genom.jpg

    How countries are using genomics to help avoid a second coronavirus wave

    28 May, 2020

    As many countries emerge from lockdowns, researchers are poised to use genome sequencing to avoid an expected second wave of COVID-19 infections.

    Since the first whole-genome sequence of the new coronavirus, SARS-CoV-2, was shared online on 11 January, scientists have sequenced and shared some 32,000 viral genomes from around the world. Such a vast amount of data has allowed researchers to trace the origin of COVID-19 outbreaks in their countries and pinpoint when communi...
  • remesdivir.jpg

    Coronavirus: UK authorises anti-viral drug remdesivir

    27 May, 2020

    A drug treatment called remdesivir that appears to shorten recovery time for people with coronavirus is being made available on the NHS. Health Secretary Matt Hancock said it was probably the biggest step forward in the treatment of coronavirus since the crisis began. Remdesivir is an anti-viral medicine that has been used against Ebola.

    Click here for reference








  • sk_covid_2.jpg

    Leveraging South Korea's Covid-19 success

    26 May, 2020

    South Koreans from all walks of lives are experiencing a strong sense of déjà vu as the Covid-19 pandemic has miraculously turned their country into the poster child for how to manage a public health crisis. The so-called "K-quarantine" and "K-testing", which have been duplicated worldwide, have added an extra layer to the existing Hallyu or "Korean Wave" of virtuosity and respectability, as the nation's actions have protected and saved lives even though the government is still fighting a...
  • Captura_de_pantalla_2020-05-25_a_las_8_53_29.png

    Coronavirus cases, hospitalizations and ICU admissions in Spain at lowest level since March

    25 May, 2020

    The daily data covering the coronavirus epidemic in Spain continued in the same direction on Sunday, according to the latest figures supplied by the Health Ministry. Once again, the majority of indicators were at low levels, while there were continuing problems with the notification of the figures from the Catalonia region.

    New infections came in at 246, hospitalizations at 86, and new intensive care unit (ICU) admissions were at three – all of which were the lowest seen since Marc...
  • _112289208_gettyimages-1212156018-1.jpg

    Hydroxychloroquine trial begins in the UK

    22 May, 2020

    A trial to see whether two anti-malarial drugs could prevent Covid-19 has begun in Brighton and Oxford.

    Chloroquine, hydroxychloroquine or a placebo will be given to more than 40,000 healthcare workers from Europe, Africa, Asia and South America.

    All the participants are staff who are in contact with Covid-19 patients.

    Click here for reference